HAM/TSP attributable to blood transfusion A multi-centric case-control study was carried out to clarify possible environmental factors related to the onset of HTLV-I-associated myelopathy' /tropical spastic paraparesis2 (HAMtTSP) in northern Kyushu, Japan, which comprises one of the most prevalent areas of HTLV-I in the world.3 The frequencies of blood transfusion before the onset of HAM/TSP were 33% (6/18) among male patients and 18% (12/67) among female patients, which were significantly higher than 8% in males and 9% in females in the general population. The ageadjusted summary odds ratios with 95% confidence intervals were 7-0 (2-9-17-0) for males and 2-4 (1-3-4-5) for females. The percentages of population attributable risk4 of HAM/TSP attributable to transfusion were estimated to be approximately 29% (5-52) for males and 11% (1-21) for females.
The fraction of HAM/TSP attributable to transfusion after the introduction of blood screening for HTLV-I, in effect since 1986 in Japan, was definitely smaller than that before the programme. Our observations seemed compatible with a marked decline in newly diagnosed HAM/TSP patients after its introduction,5 which may be part of the benefit of blood screening. Neither smoking nor drinking was related to the risk of HAM/TSP. 20-30 ms and is termed the primary peak (PP); in some motor units a secondary peak at 50-90 ms is also seen.3 PP is characteristically followed by a compensatory period of zero firing probability, which reflects the advancement of discharges that would have occurred shortly after PP had no stimulus been applied. Complete suppression of firing in response to transcranial magnetic stimulation in the absence of an excitatory peak has not been reported. 
